Clinical Trial Update: Correlating Outcomes With Biochemical Markers to Estimate Time-progression in Idiopathic Pulmonary Fibrosis (IPF)

View source ↗

Summary

A completed clinical trial evaluating whether biochemical markers can correlate with outcomes to estimate progression time in idiopathic pulmonary fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Snippet

Sponsor: University of Michigan | Conditions: Idiopathic Pulmonary Fibrosis | Status: COMPLETED